IMed Consultancy’s regulatory and quality experts support MedTech advancement across the full product spectrum, from high-risk implants to next-generation digital health technologies. We provide tailored regulatory consulting for medical devices, in-vitro diagnostics (IVDs) and companion diagnostics, software as a medical device (SaMD) and AI-enabled digital health, combination products, and borderline products.
Whatever you’re developing, our team gives you the clarity, confidence, and compliance needed to move from concept to market (and stay there) safely and efficiently.






Medical Devices
From concept to market approval across the UK, EU, and US, IMed Consultancy helps you bring safe, effective medical devices to market with clarity and speed. Our team supports every stage of the regulatory process from classification and technical documentation to post-market surveillance and remediation. Whether you are preparing your first 510(k) or MDR / IVDR submission, managing a global portfolio or navigating post market requirements, we’ll guide you through every compliance milestone with precision and confidence.
In-Vitro Diagnostics and Companion Diagnostics (CDx)
Diagnostics are evolving fast, and so are the regulations. IMed Consultancy’s IVD specialists bring deep technical and regulatory expertise to help you meet US FDA and IVDR requirements, generate performance data, and maintain compliance post-launch. We also support companion diagnostics (CDx), bridging the gap between pharma and MedTech to help you meet regulatory and clinical expectations.

Software as a Medical Device (SaMD) and AI-Enabled Digital Health
Regulating digital health demands precision and agility. IMed Consultancy helps you manage SaMD and AI/ML requirements, from IEC 62304, cybersecurity ISO 81001-5, from clinical evaluation to usability IEC 62366-1. Our consultants translate complex frameworks into clear, actionable steps so you can move fast and stay compliant in a rapidly shifting digital health landscape.
Combination Products
When your product blends device, drug, or biologic components, classification and regulation become complex. IMed Consultancy provides integrated guidance on global combination product frameworks, aligning device and pharmaceutical requirements to accelerate your route to market. From documentation to submission strategy, we ensure every component meets the highest compliance standards.

Borderline Products
If your product sits in the grey area between categories, IMed Consultancy helps you define the right regulatory pathway. Our team assesses classification, intended use, and technical evidence to guide you toward the correct designation, whether device, cosmetic, or medicinal. With clear documentation and regulator-ready rationale, we remove uncertainty and get your product moving.
Why IMed Consultancy?
Since 2012, IMed Consultancy has supported MedTech innovators, QA/RA leaders, and global manufacturers in achieving regulatory success. Our specialists combine technical depth with real-world commercial understanding, providing a partnership that feels like an extension of your own team.
